FREE 2 DAY SHIPPING ON ALL ORDERS
.png)
.png)
.png)
.png)
.png)
Compounding involves creating a medication specifically tailored to an individual's needs. For instance, a patient might require a liquid version of a medication that is only available as a pill. Additionally, pharmacies can compound medications using FDA-approved drugs that are in short supply.
These compounded drugs are prepared by state-licensed pharmacies that adhere to both FDA and state regulations, ensuring they meet quality standards. When made according to federal laws, compounded drugs do not require FDA approval and are exempt from undergoing safety, effectiveness, or manufacturing reviews.
Willow is collaborating with compounding pharmacies to provide compounded tirzepatide, which contains the same active ingredient as Zepbound® and Mounjaro®. Notably, Willow offers a compounded product that includes tirzepatide base, the active ingredient in Zepbound® and Mounjaro®, and not tirzepatide salts, which differ from the active ingredient in those medications.
Semaglutide and tirzepatide are both medications used for weight loss, but they have distinct differences.
Semaglutide is a GLP-1 receptor agonist, which helps to regulate blood sugar by enhancing insulin secretion, slowing gastric emptying, and promoting satiety.
Tirzepatide, on the other hand, is a dual agonist, targeting both the GLP-1 and GIP receptors, offering enhanced glucose control and weight loss by combining the effects of both incretin hormones. Clinical trials suggest that tirzepatide offers superior efficacy in both glucose lowering and weight reduction compared to semaglutide.
Willow collaborates with state-licensed compounding pharmacies to produce compounded tirzepatide. The practice of compounding is regulated by the FDA and state pharmacy boards. These licensed compounding pharmacies must adhere to both federal and state regulations, which encompass administrative guidelines and quality standards.
*Tirzepatide is $399/mo for most dosage levels, but changes for high concentrations. These are priced at $499/mo for 10mg and 12.5mg, and $524/mo for 15mg.
Most patients achieve their weight loss goals with common dosage levels, and do not need high concentrations.
Tirzepatide is a novel medication that works by targeting two key receptors involved in glucose and energy regulation: the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor.
By activating these receptors, Tirzepatide enhances insulin secretion in response to meals, inhibits glucagon release, and slows gastric emptying, which helps to control blood sugar levels. Additionally, it promotes feelings of fullness and reduces appetite, leading to weight loss.
The dual agonist action of Tirzepatide leverages the complementary effects of GLP-1 and GIP, resulting in improved glycemic control and significant weight reduction in patients.
As a Willow patient, you’ll be supported along your entire weight loss journey by our medical team of board certified doctors.
Have a question? Get answers and guidance with unlimited same-day doctor messaging. Our team is with you every step of the way.
Ready to transform your life with Compound Tirzepatide? Willow offers transparent pricing, high-quality medication, and dedicated support.
Starts at $399 per month. Includes prescription, medication, and free 2-day shipping.
Same-day prescriptions with no insurance required.
Unlimited same-day messaging and support from US-based board-certified doctors.
Some patients may experience side effects while on Semaglutide. The most common ones is nausea. While these side effects can be bothersome, the good news is that they usually subside over time.
Your doctor will help find the best treatment, gradually increasing the dosage for weight loss and comfort. If you have any issues, they’ll adjust the plan. Just send a message! — No appointment required.
Your doctor can also prescribe generic Zofran (Ondansetron) if needed. This optional anti-nausea medication can help with side effects.
Results could mark a "new era" in treating obesity with even more therapies on the horizon.
The most effective drug intervention we have seen for weight management.
In studies, a weekly injection caused dramatic amounts of weight loss and improved other heart-related risk factors.
2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.
.png)
These highly effective anti-obesity medications are associated with weight losses of more than 10% of overall bodyweight in more than two-thirds of clinical trial participants.
Results could mark a "new era" in treating obesity with even more therapies on the horizon.
The most effective drug intervention we have seen for weight management.
In studies, a weekly injection caused dramatic amounts of weight loss and improved other heart-related risk factors.
2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.
These highly effective anti-obesity medications are associated with weight losses of more than 10% of overall bodyweight in more than two-thirds of clinical trial participants.
Results could mark a "new era" in treating obesity with even more therapies on the horizon.
The most effective drug intervention we have seen for weight management.
In studies, a weekly injection caused dramatic amounts of weight loss and improved other heart-related risk factors.
2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight.
These highly effective anti-obesity medications are associated with weight losses of more than 10% of overall bodyweight in more than two-thirds of clinical trial participants.
We believe in a sustainable and flexible approach to nutrition, without imposing limitations on your diet. Our goal is to guide you in establishing healthy eating habits, complemented by the medication's ability to decrease appetite and “food noise”. We encourage maintaining a nourishing, high-protein diet, but most patients are able to lose weight without the need for uncomfortably restrictive dieting or calorie counting.
Common side effects of semaglutide are usually mild and may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Decreased appetite
- Indigestion
The majority of side effects are transient and typically resolve spontaneously. Nevertheless, if side effects persist or deteriorate, seek guidance from a healthcare professional.
Willow also offers Odansetron to manage side effects if they occur. This medication is commonly used to prevent nausea and vomiting.
Semaglutide Patient Safety Information
When stopping Semaglutide abruptly, some patients may experience mild to moderate weight gain. Others may maintain the weight loss they achieved while on the medication. We recommend patients work with their Willow physician to slowly decrease their dose in order to maintain their weight loss achievements.
You may notice an increase in appetite and a return of food cravings, allowing you to eat more without feeling as full. However, stopping Semaglutide is a safe and common practice that doesn't involve serious health risks. By gradually tapering off the medication with your physician’s guidance, you can better manage these changes and maintain your health and wellness goals.
Semaglutide is administered once a week via a subcutaneous injection. Don’t worry! The needle is very small and short, making self-injection quick & easy. We’ll provide you with detailed written and video instructions that make the process simple and easy to follow. We even include a link to a soothing Spotify playlist to play in the background if you wish.
